State Street
IBRX icon

State Street’s ImmunityBio IBRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$20.1M Buy
7,615,566
+31,665
+0.4% +$83.6K ﹤0.01% 2177
2025
Q1
$22.8M Sell
7,583,901
-2,201,256
-22% -$6.63M ﹤0.01% 2065
2024
Q4
$25.1M Buy
9,785,157
+1,130,697
+13% +$2.89M ﹤0.01% 2098
2024
Q3
$32.2M Buy
8,654,460
+790,408
+10% +$2.94M ﹤0.01% 1927
2024
Q2
$49.7M Sell
7,864,052
-6,320,225
-45% -$39.9M ﹤0.01% 1685
2024
Q1
$76.2M Buy
14,184,277
+4,713,368
+50% +$25.3M ﹤0.01% 1484
2023
Q4
$47.5M Buy
9,470,909
+6,751,317
+248% +$33.9M ﹤0.01% 1729
2023
Q3
$4.6M Sell
2,719,592
-57,644
-2% -$97.4K ﹤0.01% 2958
2023
Q2
$7.72M Buy
2,777,236
+127,423
+5% +$354K ﹤0.01% 2781
2023
Q1
$4.82M Sell
2,649,813
-4,086,238
-61% -$7.44M ﹤0.01% 3004
2022
Q4
$34.2M Buy
6,736,051
+86,720
+1% +$440K ﹤0.01% 1888
2022
Q3
$33M Buy
6,649,331
+4,780,807
+256% +$23.8M ﹤0.01% 1883
2022
Q2
$6.95M Sell
1,868,524
-4,891,782
-72% -$18.2M ﹤0.01% 2927
2022
Q1
$37.9M Buy
6,760,306
+544,929
+9% +$3.06M ﹤0.01% 1932
2021
Q4
$37.8M Buy
6,215,377
+897,597
+17% +$5.46M ﹤0.01% 2008
2021
Q3
$51.8M Buy
5,317,780
+1,124,160
+27% +$10.9M ﹤0.01% 1780
2021
Q2
$59.9M Buy
4,193,620
+1,861,048
+80% +$26.6M ﹤0.01% 1709
2021
Q1
$55.4M Buy
2,332,572
+1,665,411
+250% +$39.5M ﹤0.01% 1667
2020
Q4
$8.89M Buy
667,161
+133,847
+25% +$1.78M ﹤0.01% 2698
2020
Q3
$3.7M Buy
533,314
+23,973
+5% +$166K ﹤0.01% 2931
2020
Q2
$6.26M Buy
509,341
+498,841
+4,751% +$6.13M ﹤0.01% 2651
2020
Q1
$30K Sell
10,500
-3,520
-25% -$10.1K ﹤0.01% 3684
2019
Q4
$53K Sell
14,020
-7,925
-36% -$30K ﹤0.01% 3720
2019
Q3
$27K Buy
21,945
+564
+3% +$694 ﹤0.01% 3752
2019
Q2
$22K Sell
21,381
-392,755
-95% -$404K ﹤0.01% 3770
2019
Q1
$654K Buy
414,136
+2,692
+0.7% +$4.25K ﹤0.01% 3411
2018
Q4
$477K Sell
411,444
-653
-0.2% -$757 ﹤0.01% 3455
2018
Q3
$1.53M Buy
412,097
+2,868
+0.7% +$10.6K ﹤0.01% 3333
2018
Q2
$1.25M Buy
409,229
+7,774
+2% +$23.8K ﹤0.01% 3372
2018
Q1
$1.56M Buy
401,455
+33,126
+9% +$129K ﹤0.01% 3249
2017
Q4
$1.65M Buy
368,329
+11,991
+3% +$53.8K ﹤0.01% 3242
2017
Q3
$1.95M Buy
356,338
+15,331
+4% +$84.1K ﹤0.01% 3215
2017
Q2
$2.59M Buy
341,007
+117,946
+53% +$895K ﹤0.01% 3028
2017
Q1
$791K Buy
223,061
+29,610
+15% +$105K ﹤0.01% 3317
2016
Q4
$1.11M Buy
193,451
+40,848
+27% +$233K ﹤0.01% 3257
2016
Q3
$1.19M Buy
152,603
+17,333
+13% +$135K ﹤0.01% 3147
2016
Q2
$843K Buy
135,270
+10,640
+9% +$66.3K ﹤0.01% 3307
2016
Q1
$1.03M Buy
124,630
+23,497
+23% +$193K ﹤0.01% 3207
2015
Q4
$1.75M Buy
101,133
+58,708
+138% +$1.02M ﹤0.01% 3043
2015
Q3
$485K Buy
+42,425
New +$485K ﹤0.01% 3340